For those desiring to outshine the market, the strategic selection of individual stocks is paramount. Well-chosen stocks have the potential to substantially boost your wealth.
The closing price of INmune Bio Inc (NASDAQ: INMB) was $2.56 for the day, down -6.23% from the previous closing price of $2.73. In other words, the price has decreased by -$6.23 from its previous closing price. On the day, 0.97 million shares were traded. INMB stock price reached its highest trading level at $2.64 during the session, while it also had its lowest trading level at $2.45.
Ratios:
Our analysis of INMB’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 2.64 and its Current Ratio is at 2.64. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.01.
On January 28, 2025, Rodman & Renshaw started tracking the stock assigning a Buy rating and target price of $23.Rodman & Renshaw initiated its Buy rating on January 28, 2025, with a $23 target price.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Sep 30 ’24 when Moss David J bought 10,000 shares for $5.29 per share. The transaction valued at 52,868 led to the insider holds 1,285,869 shares of the business.
Tesi Raymond Joseph bought 15,380 shares of INMB for $98,048 on Sep 12 ’24. The President and CEO now owns 1,554,106 shares after completing the transaction at $6.38 per share. On Sep 12 ’24, another insider, Moss David J, who serves as the Chief Financial Officer of the company, bought 7,690 shares for $6.38 each. As a result, the insider paid 49,024 and bolstered with 1,275,869 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, INMB now has a Market Capitalization of 69734656 and an Enterprise Value of 40428564. For the stock, the TTM Price-to-Sale (P/S) ratio is 1361.20 while its Price-to-Book (P/B) ratio in mrq is 1.98. Its current Enterprise Value per Revenue stands at 808.571.
Stock Price History:
The Beta on a monthly basis for INMB is 0.98, which has changed by -0.66492146 over the last 52 weeks, in comparison to a change of 0.20277917 over the same period for the S&P500. Over the past 52 weeks, INMB has reached a high of $11.64, while it has fallen to a 52-week low of $1.89. The 50-Day Moving Average of the stock is -48.34%, while the 200-Day Moving Average is calculated to be -59.83%.
Shares Statistics:
INMB traded an average of 2.91M shares per day over the past three months and 2632740 shares per day over the past ten days. A total of 22.93M shares are outstanding, with a floating share count of 18.90M. Insiders hold about 28.90% of the company’s shares, while institutions hold 28.12% stake in the company. Shares short for INMB as of 1752537600 were 5527466 with a Short Ratio of 1.90, compared to 1749772800 on 7256955. Therefore, it implies a Short% of Shares Outstanding of 5527466 and a Short% of Float of 24.33.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
